Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
Real, source-linked trial activity for Suzhou Zelgen Biopharmaceuticals Co.,Ltd: 2 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 23, 2026. Source-linked, daily-refreshed.
PHASE3 2
Newest Suzhou Zelgen Biopharmaceuticals Co.,Ltd trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | ZG005 Plus Etoposide and Cisplatin vs. Etoposide and Cisplatin as Firs | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 13d ago | ZG005 Plus Bevacizumab vs Sintilimab Plus Bevacizumab as First-Line Th | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Suzhou Zelgen Biopharmaceuticals Co.,Ltd (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.